Reproductive System Neoplasm, Female - Gestational Trophoblastic Disease
NCT01535053
Clinical Trial Information
Trial Number: NCT01535053 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Gestational Trophoblastic Disease
Trial Title:
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia
Study ID:
GOG-0275
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01535053-D2 | There are two submissions associated with PMID 34260997. This dataset, NCT01535053-D2, contains quality of life (QOL) data from trial NCT01535053. |
| NCT01535053-D1 | There are two submissions associated with PMID 34260997. This dataset, NCT01535053-D1, contains treatment comparison data between Actinomycin-D and Methotrexate in trial NCT01535053. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®